New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new drug that protects against RSV, a common cold-like virus that can cause ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...

The American College of Obstetricians and Gynecologists (ACOG) plans to develop and release recommendations on maternal ...

More than 14 million children around the world have not received a single dose of any vaccine, according to new data from the World Health Organization and UNICEF.

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...

While your baby may not have made his big entrance yet, it's important to understand the recommended vaccines and schedule now. That's because your child’s immunizations will play a major role during ...

GSK plc GSK announced that the FDA has accepted its regulatory filing seeking to expand the use of its RSV vaccine, Arexvy, in adults under 50 who are at a higher risk of the disease. A final decision ...

The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...

The update covers the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, skin cancer ...